Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Control-IQ+ technology

K-Number: K250798 · 2025-05-21

ApplicantTandem Diabetes Care, Inc.
Decision Date2025-05-21
Product CodeQJI
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

Control-IQ+ technology is a medical device manufactured by Tandem Diabetes Care, Inc.. It received FDA 510(k) clearance on 2025-05-21 under approval number K250798. The device is classified under product code QJI. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Control-IQ+ technology?

Control-IQ+ technology is a medical device that received FDA 510(k) clearance on 2025-05-21. It is manufactured by Tandem Diabetes Care, Inc.. The 510(k) number is K250798.

When was Control-IQ+ technology approved by the FDA?

Control-IQ+ technology received FDA 510(k) clearance on 2025-05-21, under approval number K250798.

What company makes Control-IQ+ technology?

Control-IQ+ technology is manufactured by Tandem Diabetes Care, Inc..

What is the FDA product code for Control-IQ+ technology?

The FDA product code for Control-IQ+ technology is QJI.

Related Clinical Trials

NCT07430293 Hybrid Closed-Loop Insulin Delivery After Pancreatectomy RECRUITING NCT07095894 A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control NOT_YET_RECRUITING NCT06124196 Wearable Technology to Evaluate Hyperglycemia and HRV in DMD RECRUITING NCT07601997 Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reperfusion Injury (REFINE Study) NOT_YET_RECRUITING NCT07328555 Digital Otoscopy Versus Standard Otoscopy on the Diagnosis and Treatment of Otitis Media in Young Children ACTIVE_NOT_RECRUITING NCT06938412 Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation RECRUITING

Related PubMed Literature

PMID: 40246728 [Analysis of the Core Principles and Key Design and Development Control Factors of Two Typical Point-of-Care Testing Technologies]. Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation (2025)

Other Devices by Tandem Diabetes Care, Inc.

K162080t:slim Insulin Delivery System, t:flex Insulin Delivery System, Tandem Device Updater K160056t:slim Insulin Delivery System K160482t:slim Insulin Delivery System, t:flex Insulin Delivery System, Tandem Device Updater DEN190034Control-IQ Technology DEN180058t:slim X2 insulin pump with interoperable technology K200467Control-IQ Technology

View all 22 devices →

Related Devices (Code: QJI)

DEN190034Control-IQ TechnologyTandem Diabetes Care, Inc. K200467Control-IQ TechnologyTandem Diabetes Care, Inc. K220394SmartAdjust(TM) technologyInsulet Corporation K203774SmartAdjust technologyInsulet Corporation K232382Control-IQ TechnologyTandem Diabetes Care, Inc. K232224iLet® Dosing Decision SoftwareBeta Bionics, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑